top of page
Search
Writer's pictureupdatedtechforall
May 5, 20203 min read

Israel minister claims ‘breakthrough’ in developing antibody against coronavirus

Israel made significant breakthrough in developing antibody against Covid-19: Defence Minister


Israeli Defence Minister Naftali Bennett said that scientists at the country's main biological research institute have made a "significant breakthrough" in developing an antibody to the Covid-19.



Israeli Defence Minister Naftali Bennett has said that scientists at the country's main biological research institute have made a "significant breakthrough" in developing an antibody to the novel coronavirus, as the researchers wrapped up the development phase and moved to patent and mass produce the potential treatment.

Bennett visited the labs of the Israel's Institute for Biological Research (IIBR), supervised by the Prime Minister's Office and mandated to develop a vaccine for coronavirus, in Ness Ziona on Monday and was shown the "antibody that attacks the virus in a monoclonal way and can neutralize it within the bodies of those ill", a statement from his office said.

The statement said that the antibody's development had been completed and that the institute was in the process of patenting the find "and in the next stage, researchers will approach international companies to produce the antibody on a commercial scale".

"I am proud of the institute staff for this terrific breakthrough," Bennett said, adding that "their creativity and the Jewish mind brought about this amazing achievement".

In March, Israeli daily Ha'aretz, quoting medical sources, had reported that scientists at the institute had made a significant breakthrough in understanding the biological mechanism and qualities of the virus, including better diagnostic capability, production of antibodies for those who already have the virus and development of a vaccine.





Israel claims big breakthrough - says it has developed antibody against Coronavirus!


The Israel Institute for Biological Research (IIBR) has developed an antibody or passive vaccine which can attack and neutralise the virus responsible for COVID-19 within the bodies of those infected.


New Delhi: Israeli Defense Minister Naftali Bennett has confirmed that the Israel Institute for Biological Research (IIBR) has developed an antibody or passive vaccine which can attack and neutralise the virus responsible for COVID-19 within the bodies of those infected. Last month, IIBR started testing its antibody-based vaccine prototype on rodents.

Terming the development a 'major breakthrough', the minister said that he was shown the 'antibody that attacks the virus in a monoclonal way and can neutralise it within the bodies of those ill', said a statement from his office as reported The Times of Israel. 

“I am proud of the institute staff for this terrific breakthrough,” Bennett was quoted as saying in the statement. The statement from the Defense Minister's office, however, did not specify whether trials were conducted on humans.





Developed Antibody Against Coronavirus, "Terrific Breakthrough": Israel


COVID-19 Vaccine: Israeli Defence Minister Naftali Bennett was shown the "antibody that attacks the virus in a monoclonal way and can neutralize it within the bodies of those ill", a statement from his office said.



Jerusalem: Israeli Defence Minister Naftali Bennett has said that scientists at the country's main biological research institute have made a "significant breakthrough" in developing an antibody to the novel coronavirus, as the researchers wrapped up the development phase and moved to patent and mass produce the potential treatment.

Bennett visited the labs of the Israel's Institute for Biological Research (IIBR), supervised by the Prime Minister's Office and mandated to develop a vaccine for coronavirus, in Ness Ziona on Monday and was shown the "antibody that attacks the virus in a monoclonal way and can neutralize it within the bodies of those ill", a statement from his office said.

The statement said that the antibody's development had been completed and that the institute was in the process of patenting the find "and in the next stage, researchers will approach international companies to produce the antibody on a commercial scale".

"I am proud of the institute staff for this terrific breakthrough," Bennett said, adding that "their creativity and the Jewish mind brought about this amazing achievement".





5 views0 comments

Comments

bottom of page